- Home
- CURX vs SNES Comparison
CURX vs SNES Comparison
Compare CURX & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURX | SNES |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 12.1M |
| IPO Year | 2025 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CURX | SNES |
|---|---|---|
| Price | $0.45 | $1.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 192.0K | 24.6K |
| Earning Date | 09-09-2025 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.99 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $600,000.00 |
| Revenue This Year | N/A | $29.00 |
| Revenue Next Year | N/A | $95.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 132.56 |
| 52 Week Low | $0.26 | $1.54 |
| 52 Week High | $9.18 | $5.99 |
Technical Indicators
Market Signals| Indicator | CURX | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 41.62 |
| Support Level | $0.38 | N/A |
| Resistance Level | $0.53 | $1.75 |
| Average True Range (ATR) | 0.06 | 0.10 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 33.93 | 38.04 |
Price Performance
Historical ComparisonAbout CURX Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.